MSD Korea Ltd. clinical trials
A country office of Merck & Co., Inc
The registry lists 1 studies whose lead sponsor is MSD Korea Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 15, 2014.
- 1study on the registry
- 0open to participants now
What it is testing
The drugs MSD Korea Ltd.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Over the years
- 113
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- MSD Korea Ltd.1 study
Something wrong with this grouping? Tell us on the Merck & Co., Inc page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Merck & Co., Inc studies →
- Influence of Mild Hypothermia on Reversal of Rocuronium With SugammadexCompletedNCT01965067Phase 4
Sponsor listed in the registry: MSD Korea Ltd.